
Chinese pharmaceutical manufacturing company established on 8 July 2020 at Futai Road in the Taixing Economic Development Zone in Jiangsu with one hundred million US dollars of registered capital, and part of STA Pharmaceutical, the small molecule contract development and manufacturing arm of WuXi AppTec. Employs more than three thousand people at the site and supports the group's one stop offering from active pharmaceutical ingredients through to finished dosage forms for global partners, covering small molecules, oligonucleotides, peptides and complex chemical conjugates. Is investing about 5.5 billion yuan in an innovative drug research and production base adding fifteen workshops on the eastern plant, aimed at 750 tonnes a year of specialty and patented active ingredient capacity alongside pharmaceutical research services and process development.
会社プロフィールを見る
評価を残す